Emerging Cancer Therapy: Microbial Approaches and Biotechnological Tools
Explores current and emerging applications of microbes as cancer-fighting agents. Today, treatment options for cancer patients typically include surgery, radiation therapy, immunotherapy, and chemotherapy. While these therapies have saved lives and reduced pain and suffering, cancer still takes millions of lives every year around the world. In recent years, researchers have been working on a new strategy: developing microbes and microbial products that specifically attack cancer cells.
The European Society for Medical Oncology (ESMO) is to be complimented for having decided to dedicate an issue of its “Handbook” series to geriatric oncology. The International Society for Geriatric Oncology (SIOG) has been happy to help in the task of developing this volume, which was initiated by Dirk Schrijvers, Branko Zakotnik, Riccardo Audisio, Hendrik van Halteren, Arti Hurria, and the undersigned.
Now divided into four parts, the second edition of Cancer Pain delivers broad coverage of the issues that arise in the management of malignancy-related pain, from basic science, through end of life care and associated ethical issues, to therapies, both medical and complementary. Part One reviews basis considerations in cancer pain management, including epidemiology, pharmacology, history-taking and patient evaluation and teamworking. Part Two brings together the drug therapies for cancer pain, their underlying basis, and potential side-effects.
mTOR Pathway and mTOR Inhibitors in Cancer Therapy
The main objective of this book is to provide an up-to-date survey of the rapidly advancing field of cancer therapy. Moreover, since our knowledge in this area rapidly evolves, some data have got obsolete during the process of book editing. Our understanding of the mechanisms involved in cancer genesis and progression underwent unprecedented expansion during the last decade, opening a new era of cancer treatment – targeted therapy.
Because of the wealth of new information generated by the scientific community during the last decade on the role of nutrition on cancer risk, this book provides a forum for presentation and discussion of recent scientific data and highlights a set of dietary recommendations. Bioactive Compounds and Cancer presents chapters that highlight laboratory and clinical findings on how selected nutrients function as signaling molecules and, as such, influence cellular behavior and cancer predisposition.
